Research could help drug developers improve the safety profiles of medications

FHS
July 3, 2024
11:54 am

Research from the University of British Columbia, MIT, and the University of Michigan could help drug developers improve the safety profiles of medications and reduce side effects.

GSK shoots for RSV label expansion in younger adults in Europe in race against Pfizer’s Abrysvo

GSK is seeking to make its RSV vaccine the first available in Europe that protects adults as young as 50 years old. An approval would

January 30, 2024

Understanding COVID-19 mortality in people with severe mental illness and different ethnicities

In a recent study published in the British Journal of Psychiatry, researchers evaluated mortality in individuals with severe mental illness (SMI) following COVID-19.

October 31, 2023

Women more likely to experience first fragility hip fracture in their 60s

Older women with low bone density are more likely to experience their first hip fracture in their 60s compared to older ages, according to research

June 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.